chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient states she developed redness and swelling that was warm to the touch near the injection site. She reported the event to us on 12/05/2022. She was then sent to the clinic to be evaluated by a provider who diagnosed the event as cellulitis/ abscess which was treated with antibiotics. She is to follow up with the clinic on 12/12/2022.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
10 minutes after receiving vaccine patient felt warm and vomited. After vomiting the patient felt better.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On unknown date the patient was vaccinated with a dose of M-M-R II, injection, (lot # J002502, expiration date 28-FEB-2015). There was no concomitant medication reported. The nurse practitioner reported that the vaccine was exposed to a highest temperature of 11.5 degree centigrade for 22.5 hours. No adverse effect reported. This is one of several reports received from same source. Additional information has been requested.
elbow pain; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported he experienced elbow pain from his vaccine on an unspecified date. The outcome of event was unknown.  Information on the lot/batch number has been requested.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2016, the patient was inoculated with the ZOSTAVAX vaccine at a physician office as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 17-OCT-2016, the patient was treated by a physician assistant for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster. The patient was prescribed acyclovir and gabapentin for management of his painful symptoms and chronic pain. On or about 14-NOV-2016, the patient sought subsequent treatment from physician assistant for a blistering vesicular outbreak that was diagnosed as severe neuropathy. The patient was prescribed gabapentin and lidocaine for management of his painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Upon internal review, severe neuropathy was determined to be medically significant. Additional information has been requested.
Body aches, fever (+/- 101°), back ache, chills, severe headache, slightly elevated heart rate, fatigue.  Symptoms lasted approximately 24+ hours.  Moderate to severe arm soreness at site of vaccination for >36 hours and continuing
Received TDaP vaccine on 4/10. With the vaccine said it really hurt, and felt like during shot it "hit bone". Next day on 4/11 he was dizzy, fever to 102F and c/o left arm pain. Fever up to 102F on 4/12. On 4/13 fever up to 102.2F again as well as chills. Seen in office that day (4/13). He had some waves of nausea, body aches and joint pain as well as soreness in Left ribs and left axilla. Left armpit swollen and L arm a little swollen. Seen again in office on 4/14 due to fevers continuing up to 100.5F. Feeling better on 4/14 but outer arm felt bruised and lump under arm still present. Has better ROM of L arm with less pain during movement. No skin redness or warmth. Low concern for cellulitis/lymphadenitis. Suspect Vaccine reaction with reactive lymphadenopathy.
We had a family reunion on June 23, 2022 everyone came from all over. No one knew that they had been infected until they started feeling bad. My husband and I were contacted so we tested using our home COVID-19 test that came back positive. I called the doctor who advised me to go to urgent care. Urgent care did not see me they only advised us to quarantine. I have been feeling dizzy but I do have a bladder infection.
pt recvd MMR vax 21DEC92 on 31DEC92 pt devel t101-102 & rash;
Office Visit  10/18/2021 Urgent Care  PA-C  Family Medicine Exposure to COVID-19 virus +1 more  Dx Cough   Reason for Visit  10/18/2021 Chief Complaint Patient presents with ? Cough     mild , exposure to covid     HPI   Assessment/Plan   Pt was seen today for cough.   Diagnoses and all orders for this visit:   Exposure to COVID-19 virus -     COVID-19 PCR   URI, acute   Pt is a 82 y.o. male Presents with slight cough  x 3 days. Symptoms are stable .Patient has tried cough suppressant with moderate relief.  Patient denies fever/chills, ST, nausea/vomiting, diarrhea, abdominal pain, rash, neck stiffness, chest pain, shortness of breath, dizziness.  +covid exposure
The vaccine caused my mother delirium hallucinations speaking to voices paranoia and feeling aggressively stalked. This went on for maybe 8 months.She could not sleep for days at a time until exhaustion and she kept seeing invisible animals and hairy men. She was devastated.
A spontaneous report has been received from a Health Professional concerning a 02 year old, male patient. No information regarding medical history, concomitant disease or concomitant medication was provided. The patient was receiving Nasal FLUMIST (intranasal) started on an unknown date. The reporter stated that one their patients had a fever 102 Degree Fahrenheit on and tested positive for the flu which started on 27-Nov-2012 a few weeks after receiving FLUMIST. The outcome of the events of fever and tested positive for the flu was unknown.  The reporter considered the events fever and tested positive for the flu as non-serious.
From initial information received on 21APR2004 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 36 year old male patient received a first dose of YFVAX, administered SC in the left arm on 08MAR2004 at 8:30Am. Approximately two weeks later, about 22MAR2004, the patient experienced polymyalgias and paresthesias following a sore throat. It was reported that the patient could have experienced a possible viral syndrome. The patient had partially recovered from these events at the time of this report.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored MMR II lot # K024036, expiration date: 26-NOV-2016, lot # K003823, expiration date: 14-MAR-2016 and lot # reported as L015282, expiration date: 30-APR-2017 (dose and route of administration were not reported). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
DECREAESED APPETITE FOR 2 DAYS, CRIED OFF AND ON FOR 1 DAY  TREAT PATIENT WITH TYLENOL AT HOME, ENCOURAGE FLUIDS BY MOUTH, FOLLOW UP APPOINTMENT WITH DOCTOR IF NOT BETTER IN 2 DAYS
Patient admitted to hospital with chest pain and elevated troponin.  Patient diagnosed with myopericarditis possibly secondary to viral illness vs post COVID vaccination.  Starting on 09/07/2021, patient started experiencing chest pain. Due to an increase in pain, patient went to the ED.   Patient had COVID-19 about 9 months prior.  Patient had recent viral illness (gastroenteritis 3 weeks ago).  Treated with ibuprofen 400mg every 8 hours scheduled.  Myopericarditis resolved by 10/04/2021 (follow up Cardiology Visit)
I woke up in the middle of the night after receiving the 2nd round of the shingles vaccine with chills and felt feverish. When I got up in the morning, I felt flu like symptoms - general malaise, nausea, and feverish. Throughout the morning it got worse and by about noon I was lightheaded and unable to work. I clocked my fever at 101.1. I took a nap and took some aspirin and my fever was gone by about 3-4pm that day. I was tired and still felt flu-ish the rest of the evening but after sleeping through the night I felt fine the next day. The site of the vaccine shot (upper left arm) was very red, felt warm and hard, and had raised red welts around it, about 1" plus radius around the injection for the first day. The second day the shot site was red and warm and tender but clearly improving. It remained warm and red/slightly swollen for two more days. I also had a reaction after the first round of the shingles vaccine that was similar, but quite a bit more mild. I didn't notice anything besides soreness at the injection site but I felt like I had a 24 hr flu after the first shot (nausea, exhaustion, feverish). I've never had any allergies or reactions before to medicine or vaccines other than basic soreness where I received a shot.
Patient reported mild tingling in her leg and face, which lasted for a few minutes (unknown time course). Denied any swelling of the face, swelling of the tongue, rash, itching, cough, shortness of breath or chest tightness.
vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low; Vaccine administered to 45 patients past 30-day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date) and PRODUCT STORAGE ERROR (vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 068H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date) and PRODUCT STORAGE ERROR (vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. The vaccine was stored in standard freezer on 04-Jan-2022. No treatment medications were provided.
This spontaneous report as received from a female patient of unknown age reporting on herself. On 29-MAR-2015, the patient was vaccinated with ZOSTAVAX (dose, lot number, expiration date, route of administration were not reported). On unspecified date in 2015, the patient experienced redness, warmth and a hard lump on her arm where she received ZOSTAVAX. The patient sought medical attention: called a health care professional (unspecified, on an unknown date). The outcome of the events was not reported. Relatedness between the events and vaccination with ZOSTAVAX was not reported. Additional information is not expected as there is no contact information available.
SWELLING IN THROAT THE NIGHT FOLLOWING VACCINATION AND AND SWELLING IN FACE THE FOLLOWING DAY.
At approximately 6 AM upon waking up I felt lethargic and soreness at the injection site. Also had hives around the shoulder and neck and chest area. And also swelling in the face and extremities (hands and feet). This lasted all day on the 22nd. Ibuprofen and Benadryl did seem to help.
Vaccine given on March 4.  On March 13 there was pain shooting out of left breast and left armpit was throbbing and hurting down my arm.  On Tuesday March 16 I looked up self massage for lymphatic swelling and gave myself a massage to the affected area.  Then today March 18, I saw my personal massage therapist and she did lymphatic release and said that my left arm and armpit across my chest area lymph nodes were swollen and she worked to open them.  I will return on Monday for another treatment.
This case was reported by a physician, via a sales representative, and described the occurrence of burning (nos) in a child subject of unspecified gender who was vaccinated with HAVRIX, GlaxoSmithKline.  It was unknown if other vaccines were given on the same day as HAVRIX.  On an unspecified date the subject received unspecified dose of HAVRIX (.5 ml, unknown).  At an unspecified time after vaccination with HAVRIX, the subject experienced burning (nos) and crying.  It was noted that this practice did not have the same issues with VAQTA and they also commented that they did not like the prefilled syringes.  At the time of reporting the outcome of the events were unspecified.  It was noted that these events occurred in "pediatric patients."
Client reported that she developed dry mouth and it felt ?hard to swallow? about 5-10 minutes after receiving the second dose of Moderna COVID vaccine. The client stated the episode of symptoms lasted about 15 minutes. The client denied feeling any shortness of breath.
Unexpected rash on arms and legs seen around 1 am (when I woke up in the night last night) and it is still there at 7 am but is fading.
1 to 3 seizures lasting 8-18 seconds each per day, including memory loss.  Child did not report until she had an accident in school Oct. 1, 2010.  ER twice, family doctor, neurologist, EEG confirms seizure activity.
Erythema, inflammation approximately 1" diameter at (L) posterior arm (upper arm) & tenderness with palpation. Recommended cool compresses & ibuprofen.
Patient developed swollen, warm, reddened area about 10 minutes after vaccines given.  Advised mom to apply warm compress and monitor as well as give pt pain relief med once they get home.
After I got the injections, (she told me that I would probably have a sore arm) I asked her to give it to me in my left arm, she injected me in the left arm. I went home and started resting. Then I started having asthma attacks, I got itching, I started wheezing and coughing. I developed a headache. Then my gums swell up on the right side. Usually when my gum swell up on the right side, I have an issue. They were fat pulling away from my gums. Still wheezing, coughing, looking for releif from my gums. I took an asprin and put it on there, trying to get releif, I took pain pill trying to get releif, still nothing. The next day, I asked for the pharmacist. They were suppose to give me a pneumo vax, but they didnt have it. I asked for the pharmacist and I also asked for cyclo hexodine- mouthwash my dentist gives me. I spoke to the pharmacist finally. I told her about how I was feeling, and it was horrible. By the time I had talked to her, the wheezing had stop, I am on cymbocort for asthma. I have asthma. I was using it for 9.1.22 - 9.2.22.
Information and follow-up information has been received from a physician concerning a patient who was inadvertently vaccinated with a dose of Pneumovax 23 instead of a fourth dose Prevnar. The physician stated that there was an error on the part of the office. Specifically, 70 doses of Pneumovax 23 were ordered instead of Prevnar because both products were next to each other on the order form. It was reported that 40 degrees were administered with the belief that they were Prevnar. It was reported that there was no confusion in regards to product packaging. The physician stated that the problem had been corrected at the office and did not foresee any future problems. On an unspecified date, the patient was vaccinated with a fourth dose of Prevnar. At the time of the report, there were no adverse experiences reported. Follow-up reported that the patient had "done well." No pneumococcal infections have been noted. Additional information is not expected.
No additional AE/PQC was reported; improperly stored VARlVAX was administered; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.  On 31-AUG-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # T006347, expiration date 20-FEB-2022) for prophylaxis (product storage error).Temperature excursion was 18.1 Fahrenheit degree for 408 hours 0 minutes and 0 seconds. Previous temperature excursions were - 7.0 Fahrenheit degree for 0 hours 20 minutes and 0 seconds; 7.7 Fahrenheit degree for 0 hours 15 minutes and 0 seconds; 5.4 Fahrenheit degree for 0 hours 5 minutes and 0 seconds. No additional AE was reported.  This is one of four reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA003330: US-009507513-2109USA003760: US-009507513-2109USA003761:
First 3 days soreness in muscle of arm, normal reaction I've had from big shots. Then pain in joint of shoulder started about day 4 after10 days soreness in joint promenent especailly when raising arm above shoulder height. Went into doctor and got a cortisone shot in shoulder on day 11. Pain went away about 3 days later.
Less than 24 hours after receiving FLU-MIST had 102 - 103 temp / body aches / cough, Sx's for about 2-3 days.
This spontaneous report as received from a healthcare worker (C.M.A.) refers to a patient of unknown age. On 16-DEC-2010, the patient was vaccinated with first dose of GARDASIL (dose, route, injection site, lot# not provided). On 30-JAN-2014 the patient came to the office late to vaccinated with the second dose of GARDASIL (dose, route, injection site, lot# not provided). No adverse symptoms reported. Additional information has been requested.
Chills, headache, fatigue, vomiting. Body aches. Red, warm, knotted injection site that went from the size of a golf ball on 10/15/21 to the size of a baseball on 10/16/21. Lymph nodes under left arm and on left collar bone sore.
Symptoms began approximately 12 hours post vaccine. Extreme body chills lasted approximately 12 hours. Extreme headache lasted for approximately 18 hours. Tiredness (NOT sleepiness) lasted for 18 hours. 36 hours post vaccine, I was feeling much better.
Blood sugar was elevated. / was 170; This case was reported by a consumer via call center representative and described the occurrence of blood sugar increased in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th April 2021, the patient received the 1st dose of Shingrix (intramuscular). On 8th April 2021, 2 days after receiving Shingrix, the patient experienced blood sugar increased. On an unknown date, the outcome of the blood sugar increased was not recovered/not resolved.   It was unknown if the reporter considered the blood sugar increased to be related to Shingrix.  Additional details was reported as follows: The patient received Shingrix and experienced blood sugar increased. The patient checked her blood sugar level on the day of reporting and her blood sugar was elevated. Her blood sugar was 170. The patient wanted to know if the Shingrix Vaccine causes an increase in blood sugar. Medical disclaimer provided to the patient. Shingrix PI used. Medial information number provided but refused. Shingrix PI provided but refused. The patient was referred to her healthcare provider. The patient was unable to provide the healthcare providers fax number, address, name of facility, expiration date of vaccine, and lot number of vaccine. The patient consented to follow up.
first dose in October 2021; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (1st dose of Twinrix vaccine received in October 2021).   On an unknown date, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient did not receive the 2nd dose of Twinrix adult till the time of reporting, which led to incomplete course of vaccination. The reporter consented to follow up by phone.
Pfizer on 2/25 and 3/18. Positive on 8/20 admitted 8/20-current
After receiving 3 vaccines (ENGERIX, MMR II, and GARDASIL), the patient went to consultation window. She had received all these vaccines previously. She began to look pale and slouch over. I (pharmacist) asked if she was feeling alright. She replied, "I am okay" then passed out/fell backwards onto her buttocks then further onto her back. She quickly got back up and I helped her to a chair. She said she felt dizzy before passing out but that she felt fine now. She drank some water and then felt she was able to go. She did not require medical attention.
PATIENT RECIEVED ANTHRAX VACCINE ON 15 OCT 2014. PATIENT RETURNED TO CLINIC 24HRS LATER WITH REDNESS AND SWELLING AT THE INJECTION SITE, SIZE 8MM BY 9MM. PATIENT WAS TREATED WITH BENADRYL 50MG/MEDROL DOSE PACK/ZANTAC 150MG.
After the vaccination the baby felt feverish and listless. Later in the evening of the vaccination, the baby started shaking violently, turned blue, and appeared to have trouble breathing. By the time rescue got there, the baby had started breathing, but was still blue and very cold. I was asked what had happened to the baby that day, and told them it was the day she got her first dose of the vaccination DTaP. When I took her to the health department the next time, and explained what had happened, I was told she is allergic to Pertussis. I didn't know I could report this until today, 28 years after the incident. She's since, never had any Pertussis.
Pt was sitting on exam table. Received MENACTRA first in (L) arm then TRUMENBA in (R) arm. Right after 2nd vaccine episode of syncope causing Pt to fall onto exam room floor, striking head-leading to altered level of consciousness. Transported via squad to ED.